GTPBP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.385699999774E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.11310000503207E-08 |
Normal-vs-Stage2 |
3.461700E-02 |
Normal-vs-Stage3 |
2.556800E-03 |
Normal-vs-Stage4 |
1.031020E-04 |
Stage1-vs-Stage2 |
6.870400E-02 |
Stage1-vs-Stage3 |
2.572600E-01 |
Stage1-vs-Stage4 |
7.246600E-01 |
Stage2-vs-Stage3 |
4.951800E-01 |
Stage2-vs-Stage4 |
1.119370E-01 |
Stage3-vs-Stage4 |
3.032200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.47689999954837E-07 |
Normal-vs-AfricanAmerican |
1.55625999999076E-05 |
Normal-vs-Asian |
3.459700E-02 |
Caucasian-vs-AfricanAmerican |
8.561600E-01 |
Caucasian-vs-Asian |
7.662800E-01 |
AfricanAmerican-vs-Asian |
6.959600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.70329999999086E-08 |
Normal-vs-Female |
8.992100E-04 |
Male-vs-Female |
1.483530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.214300000005E-05 |
Normal-vs-Extreme_Weight |
5.32689999888092E-08 |
Normal-vs-Obese |
1.64889999999529E-05 |
Normal-vs-Extreme_Obese |
1.359160E-01 |
Normal_Weight-vs-Extreme_Weight |
5.845800E-01 |
Normal_Weight-vs-Obese |
8.629600E-01 |
Normal_Weight-vs-Extreme_Obese |
6.333400E-01 |
Extreme_Weight-vs-Obese |
3.929000E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.990200E-01 |
Obese-vs-Extreme_Obese |
7.336800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.27820000000745E-05 |
Normal-vs-Age(41-60Yrs) |
2.81079999997491E-06 |
Normal-vs-Age(61-80Yrs) |
5.70239999997391E-07 |
Normal-vs-Age(81-100Yrs) |
5.83469999981823E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.722600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.661600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.430400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.926400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.107500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.834000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.68610000300862E-08 |
Normal-VS-Type2 PRCC |
2.551700E-04 |
Normal-VS-KIRP CIMP |
2.770900E-04 |
Normal-VS-Unclassified PRCC |
1.698750E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.153020E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.205800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.892650E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.932780E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.576800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.185600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.84870000039272E-07 |
Normal-vs-N1 |
3.044200E-04 |
Normal-vs-N2 |
2.41329999999262E-05 |
N0-vs-N1 |
3.117400E-01 |
N0-vs-N2 |
1.097410E-01 |
N1-vs-N2 |
3.136300E-02 |
|
|